ESR2 and breast cancer: The combinatorial effect of cisplatin, paclitaxel or tamoxifen with genistein was studied in breast cancer cell lines with different ERα/ERβ ratio: MCF-7 (high ratio), T47D (low ratio), MCF-7 overexpressing ERβ.